Underestimated Peripheral Effects Following Pharmacological and Conditional Genetic Microglial Depletion
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Microglia, predominant parenchymal resident macrophages in the central nervous system (CNS), are crucial players in neurodevelopment and CNS homeostasis. In disease conditions, pro-inflammatory microglia predominate over their regulatory counterparts, and are thus a potential immunotherapeutic target. It has been well documented that microglia can be effectively depleted using both conditional genetic Cx3cr1Cre-diphtheria toxin receptor (DTR)/diphtheria toxin subunit A (DTA) animal models and pharmacological colony-stimulating factor 1 receptor (CSF1R) inhibitors. Recent advances using these approaches have expanded our knowledge of the multitude of tasks conducted by microglia in both homeostasis and diseases. Importantly, experimental microglial depletion has been proven to exert neuroprotective effects in an increasing number of disease models, mostly explained by reduced neuroinflammation. However, the comprehensive effects of additional targets such as circulating monocytes and peripheral tissue macrophages during microglial depletion periods have not been investigated widely, and for those studies addressing the issue the conclusions are mixed. In this study, we demonstrate that experimental microglial depletion using both Cx3cr1CreER/+Rosa26DTA/+ mice and different doses of CSF1R inhibitor PLX3397 exert crucial influences on circulating monocytes and peripheral tissue macrophages. Our results suggest that effects on peripheral immunity should be considered both in interpretation of microglial depletion studies, and especially in the potential translation of microglial depletion and replacement therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525 · cited 1×
“Microglia are resident macrophages in the central nervous system (CNS), acting as key players in immune surveillance, neural circuits and synapse formation [1].”
BackgroundAn atlas of the protein-coding genes in the human, pig, and mouse brain
Sjöstedt, E., Zhong, W., Fagerberg, L., Karlsson, M., Mitsios, N., Adori, C., Oksvold, P., Edfors, F., Limiszewska, A., Hikmet, F., et al. (2020) · Science · doi:10.1126/science.aay5947 · Cited by 1,151 · cited 1×
“Recent sophisticated analysis of protein-coding genes across different species convincingly demonstrated that a variety of microglial signature genes are also highly enriched in the selective peripheral organs, such as in the circulation and lymphoid tissues [29].”
BackgroundBruttger, J., Karram, K., Wörtge, S., Regen, T., Marini, F., Hoppmann, N., Klein, M., Blank, T., Yona, S., Wolf, Y., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.012 · Cited by 634 · cited 2×
“Specifically, Cx3cr1Cre-diphtheria toxin receptor (DTR) mouse, with a tamoxifen-inducible Cre-recombinase expressed under control of the Cx3cr1 promoter, was bred in order to deplete microglia after the activation of tamoxifen and intraperitoneal administration of diphtheria toxin [7].”
BackgroundRepopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner
Willis, E. F., MacDonald, K. P. A., Nguyen, Q. H., Garrido, A. L., Gillespie, E. R., Harley, S. B. R., Bartlett, P. F., Schroder, W. A., Yates, A. G., Anthony, D. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.013 · Cited by 520
Cronk, J. C., Filiano, A. J., Louveau, A., Marin, I., Marsh, R., Ji, E., Goldman, D. H., Smirnov, I., Geraci, N., Acton, S., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180247 · Cited by 412
Elmore, M. R. P., Hohsfield, L. A., Kramár, E. A., Soreq, L., Lee, R. J., Pham, S. T., Najafi, A. R., Spangenberg, E. E., Wood, M. A., West, B. L., et al. (2018) · Aging Cell · doi:10.1111/acel.12832 · Cited by 380 · cited 1×
“PLX5622, a more specific CSF1R inhibitor that does not inhibit c-Kit, at a dose of 1200 mg/kg for 7 days can eliminate over 85% of microglia in the brain [19].”
BackgroundLei, F., Cui, N., Zhou, C., Chodosh, J., Vavvas, D. G., & Paschalis, E. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922788117 · Cited by 322 · cited 2×
“It has also been recently proposed that PLX5622 is not microglia specific and can also exert significant influences on peritoneum, lung, and liver tissue macrophages, with the splenic populations being less affected [26].”
BackgroundLund, H., Pieber, M., Parsa, R., Han, J., Grommisch, D., Ewing, E., Kular, L., Needhamsen, M., Espinosa, A., Nilsson, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07295-7 · Cited by 249 · cited 3×
“Both Cx3cr1CreER/+Rosa26DTA/+ and Cx3cr1CreER/+ mice were administered 5 mg (200 μL) tamoxifen subcutaneously on three consecutive days, as previously described by our research group [9,10].”
BackgroundMethodSelf-citation
Cited by
Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice
Kiani Shabestari, S., Morabito, S., Danhash, E. P., McQuade, A., Sanchez, J. R., Miyoshi, E., Chadarevian, J. P., Claes, C., Coburn, M. A., Hasselmann, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110961 · Cited by 167
“In addition, surviving microglia quickly proliferate to repopulate the microglial niche so that the long-term consequences of microglia absence with such models cannot be effectively studied (Bruttger et al., 2015; Han et al., 2020; Lund et al., 2018; Pons et al., 2020, 2021).”
Li, T., Zhao, J., Xie, W., Yuan, W., Guo, J., Pang, S., Gan, W.-B., Gómez-Nicola, D., & Zhang, S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02127-w · Cited by 72
“Evidence suggests that an increase in circulating neutrophils is detected as a result of Ta injections [72], which may effect the pathological progression.”
Han, J., Sarlus, H., Wszolek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01093-3 · Cited by 65
Self-citationEvidence of Microglial Immune Response Following Coronavirus PHEV Infection of CNS
Zhang, J., Li, Z., Lu, H., Shi, J., Gao, R., Ma, Y., Lan, Y., Guan, J., Zhao, K., Gao, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.804625 · Cited by 10
Metadata
- Authors
- Han, J., Fan, Y., Zhou, K., Zhu, K., Blomgren, K., Lund, H., Zhang, X.-M., & Harris, R. A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-15
- Volume
- 21
- Issue
- 22
- Pages
- 8603
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3100470435
- Cited by
- 42
- References
- 13
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Underestimated Peripheral Effects Following Pharmacological and Conditional Genetic Microglial Depletion. https://app.cochat.ai/papers/10.3390/ijms21228603
- The paper
- Han, J., Fan, Y., Zhou, K., Zhu, K., Blomgren, K., Lund, H., Zhang, X.-M., & Harris, R. A. (2020). Underestimated Peripheral Effects Following Pharmacological and Conditional Genetic Microglial Depletion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21228603
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.